Evaluation of a Center of Research Excellence in Polycystic Ovary Syndrome as a Large-Scale Collaborative Research Translation Initiative, Including Evaluating Translation of Guideline Impact

Abstract

Research translation and evaluation are often underconsidered in research design and implementation thus limiting research benefit to the end user. In this article, we first describe a best practice approach to evaluation, for a center of research excellence in polycystic ovary syndrome. Within this, we outline a comprehensive research translation program with inbuilt evaluation of the first International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2018). We seek to provide a real-world example of comprehensive approaches to evaluation and research translation.

Keywords

polycystic ovary syndrome - evaluation - research translation - best practice

• References

• 1 March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25 (02) 544-551
• 2 Boyle JA, Cunningham J, O'Dea K, Dunbar T, Norman RJ. Prevalence of polycystic ovary syndrome in a sample of indigenous women in Darwin, Australia. Med J Aust 2012; 196 (01) 62-66
• 3 Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012; 27 (10) 3067-3073
• 4 Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370 (9588): 685-697
• 5 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
• 6 Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril 2017; 107 (06) 1380-1386.e1
• 7 Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2017; 32 (05) 1075-1091
• 8 Teede HJ, Misso ML, Deeks AA. , et al; Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (06) S65-S112
• 9 Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017; 102 (02) 604-612
• 10 Boyle J, Xu R, Gilbert E. , et al. AskPCOS: Identifying need to inform evidence-based app development for polycystic ovary syndrome Semin. Reprod Med 2018; 36 (01) 64-73
• 11 Misso ML, Tassone EC, Costello MF. , et al. Large scale evidence-based guideline development engaging the international PCOS community. Semin Reprod Med 2018; 36 (01) 30-36
• 12 Xie J, Burstein F, Garad R, Teede H, Boyle J. Personalized mobile tool AskPCOS delivering evidence-based quality information about polycystic ovary syndrome. Semin Reprod Med 2018; 36 (01) 74-80
• 13 Teede HJ, Costello MF, Dokras A. , et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018;11(03)
• 14 Robinson T, Skouteris H, Melder A. , et al. Application of Monash Centre for Health Research and Implementation framework to development of PCOS guideline: a case study on implementation. Semin Reprod Med 2018; 36 (01) 13-18
• 15 Francis LJ, Smith BJ. Toward best practice in evaluation: a study of Australian health promotion agencies. Health Promot Pract 2015; 16 (05) 715-723
• 16 Lobo R, Petrich M, Burns SK. Supporting health promotion practitioners to undertake evaluation for program development. BMC Public Health 2014; 14: 1315
• 17 Swinburn B, Bell C, King L, Magarey A, O'Brien K, Waters E. ; Primary Prevention Group of the Australian Childhood and Adolescent Obesity Research Network. Obesity prevention programs demand high-quality evaluations. Aust N Z J Public Health 2007; 31 (04) 305-307
• 18 Owen JM. Program Evaluation: Forms and Approaches. 3rd ed. New South Wales, Australia: Allen & Unwin; 2006
• 19 Moore G, Audrey S, Barker M. , et al. Process evaluation of complex interventions: Medical Research Council guidance. British Medical Journal 2015;350(h1258)
• 20 A Framework for Program Evaluation. Centers for Disease Control and Prevention. . Available at: https://www.cdc.gov/mmwr/PDF/rr/rr4811.pdf . Updated May 15, 2017. Accessed July 18, 2018
• 21 Centre for Disease Control and Prevention. A Framework for Program Evaluation. Atlanta, USA. Available at: http://www.cdc.gov/eval/framework/ . Accessed August 15, 2015
• 22 Lingard L, Albert M, Levinson W. Grounded theory, mixed methods, and action research. British Medical Journal 2008; 337(a567)
• 23 Straus SE, Tetroe J, Graham I. Defining knowledge translation. CMAJ 2009; 181 (3-4): 165-168
• 24 Graham ID, Logan J, Harrison MB. , et al. Lost in knowledge translation: time for a map?. J Contin Educ Health Prof 2006; 26 (01) 13-24
• 25 Greenhalgh T. What is this knowledge that we seek to “exchange”?. Milbank Q 2010; 88 (04) 492-499